Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
FDA Seeks To Reassure Public On Generic Drug Oversight Following Valsartan Recalls May 22, 2019 Irvin Jackson Add Your Comments Federal regulators are attempting to reassure the public that about the safety of generic drugs, particularly those made in foreign countries, after a series of massive valsartan recalls issued in recent months due to cancer-causing impurities that were allowed to contaminate much of the U.S. supply for the widely used blood pressure drug. In a blog post on May 17, FDA Associate Commissioner for Regulatory Affairs, Melinda K. Plaisier, wrote that consumers can still rely on the U.S. Food and Drug Administration (FDA) to ensure the quality and safety of generic drugs. “Generic drugs are just as safe and effective as their brand counterparts and FDA stands behind the rigorous standards and regulatory inspections that go into ensuring the safety and quality of all generic drugs,” Plaisier wrote. “These standards and inspections apply equally to generic and innovator drugs – domestically and around the world.” VALSARTAN LAWSUITS Were you prescribed contaminated Valsartan drugs? Side effects of recalled valsartan may increase the risk of cancer, due to an impurity discovered in certain generic versions of the hypertension drug. Learn More SEE IF YOU QUALIFY FOR COMPENSATION VALSARTAN LAWSUITS Were you prescribed contaminated Valsartan drugs? Side effects of recalled valsartan may increase the risk of cancer, due to an impurity discovered in certain generic versions of the hypertension drug. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The message comes after concerns were raised by a former FDA inspector who suggested the agency may have ignored signs of problems at facilities in China and India where valsartan and other hypertension drugs contaminated with carcinogenic impurities were manufactured. In July 2018, the FDA began an ongoing series of recalls for valsartan, indicating that pills have been distributed for years with traces of N-nitrosodimethylamine (NDMA), N-Nitrosodiethylamine (NDEA) or N-Nitroso-N-methyl-4-aminobutyric acid (NMBA). The chemicals are believe to be a byproduct of the generic drug manufacturing process, and are all known human carcinogens, which have now been linked to reports of liver cancer, kidney cancer, gastric cancer and other digestive tract cancers among individuals who received the tainted valsartan. The recalled valsartan ingredients were manufactured primarily by Zhejiang Huahai Pharmaceutical Co. in China and Hetero Labs in India, impacting most of the U.S. supply for the blood pressure drug. The blog post came one week after an NBC News investigative report, in which a former inspector warned that the valsartan recalls are just the “tip of the iceberg” and that the agency is failing to adequately inspect drug manufacturing facilities worldwide, potentially putting U.S. patients in danger. Former FDA inspector Massoud Motamed also said the recalls were indicative of more systemic problems, warning that the FDA’s inspectors are understaffed and underfunded, preventing the agency from keeping up with inspections of foreign facilities. As a result, foreign manufacturers have an easy time hiding problems from the U.S. regulators, he said. Plaisier’s blog post appears to attempt to indicate this is not a problem, saying that the FDA effectively prioritizes inspections based on threat. “The globalization of the manufacturing industry and supply chain is simply huge, and no one inspectorate can inspect it all,” she wrote. “Wherever possible, inspectorates need to share information and discuss respective regulatory decisions so that global partners can learn from each other.” She said the FDA does this effectively, and the agency’s risk-based assessments allow it to maintain a high state of global vigilance on the drug supply chain. Several manufacturers of recalled valsartan tablets, including Hetero Labs and Zhejaing Huahai, face a growing number of valsartan lawsuits filed over claims the tainted pills caused liver cancer, stomach cancer, kidney cancer, and other malignancies after years of exposure. There are also a number of valsartan class action lawsuits being pursued by plaintiffs who seek reimbursement for the cost of what were essentially worthless drugs, as well as funding for medical monitoring which former users may require for the rest of their lives due to exposure to the cancer-causing chemicals. Tags: Cancer, Drug Recalls, Generic Drug, Hypertension, Valsartan More Valsartan Lawsuit Stories Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 July 7, 2025 Court Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases May 28, 2025 Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named March 27, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Over 550 Depo-Provera Lawsuits Being Pursued by Women With Meningioma Brain Tumors (Posted: today) As the Depo-Provera MDL moves toward its first jury trials, the litigation has reached a key milestone, with more than 550 lawsuits filed over brain tumor injuries linked to the birth control injection. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (07/09/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025) Suboxone Injury Lawyers Reappointed to Leadership Roles in Federal MDL (Posted: yesterday) A federal judge has confirmed the reappointment of more than two dozen Suboxone injury lawyers to serve in leadership positions representing plaintiffs for another year. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITGas Station Heroin Class Action Lawsuit Filed Over Addictive Properties of ZaZa Supplements (07/03/2025)Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery (05/22/2025)500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (04/24/2025) Uber Faces Lawsuit Indicating Driver Raped Passenger After Using Wife’s Account (Posted: 5 days ago) A lawsuit filed by a Florida woman says she was raped after an Uber driver’s husband showed up behind the wheel. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJudge Rejects Uber’s Attempt To Dismiss All Driver Sex Assault Bellwether Lawsuits (07/15/2025)Uber Driver Background Check Materials Must Be Produced in Sexual Assault Lawsuits: Court (06/17/2025)MDL Judge Updated on Uber Driver Sex Assault Lawsuit Status as Claims Top 2,800 (06/06/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 July 7, 2025
Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named March 27, 2025
Over 550 Depo-Provera Lawsuits Being Pursued by Women With Meningioma Brain Tumors (Posted: today) As the Depo-Provera MDL moves toward its first jury trials, the litigation has reached a key milestone, with more than 550 lawsuits filed over brain tumor injuries linked to the birth control injection. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (07/09/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)
Suboxone Injury Lawyers Reappointed to Leadership Roles in Federal MDL (Posted: yesterday) A federal judge has confirmed the reappointment of more than two dozen Suboxone injury lawyers to serve in leadership positions representing plaintiffs for another year. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITGas Station Heroin Class Action Lawsuit Filed Over Addictive Properties of ZaZa Supplements (07/03/2025)Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery (05/22/2025)500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (04/24/2025)
Uber Faces Lawsuit Indicating Driver Raped Passenger After Using Wife’s Account (Posted: 5 days ago) A lawsuit filed by a Florida woman says she was raped after an Uber driver’s husband showed up behind the wheel. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJudge Rejects Uber’s Attempt To Dismiss All Driver Sex Assault Bellwether Lawsuits (07/15/2025)Uber Driver Background Check Materials Must Be Produced in Sexual Assault Lawsuits: Court (06/17/2025)MDL Judge Updated on Uber Driver Sex Assault Lawsuit Status as Claims Top 2,800 (06/06/2025)